$MRK
Merck & Co., Inc. Stock $mrk

$mrk Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000031015818000005 Filed on February 27, 2018

Income Statement

Concept	2017 Q4	2016 Q4	2015 Q4
Revenue	$10.43B	$10.12B	$10.22B
YoY Change	3.14%	-0.98%	-2.55%
Cost Of Revenue	$3.515B	$3.439B	$3.736B
YoY Change	2.21%	-7.95%	2.52%
Gross Profit	$6.918B	$6.676B	$6.479B
YoY Change	3.62%	3.04%	-5.25%
Gross Profit Margin	66.31%	66.0%	63.43%
Selling, General & Admin	$2.820B	$2.822B	$2.560B
YoY Change	-0.07%	10.23%	-8.14%
% of Gross Profit	40.76%	42.27%	39.51%
Research & Development	$2.182B	$1.402B	$1.693B
YoY Change	55.63%	-17.19%	-18.64%
% of Gross Profit	31.54%	21.0%	26.13%
Depreciation & Amortization	$1.128B	$1.155B	$1.560B
YoY Change	-2.34%	-25.96%	-0.83%
% of Gross Profit	16.31%	17.3%	24.08%
Operating Expenses	$5.002B	$4.224B	$4.253B
YoY Change	18.42%	-0.68%	-12.63%
Operating Profit	$1.916B	$2.452B	$2.226B
YoY Change	-21.86%	10.15%	12.99%
Interest Expense	$268.0M	-$207.0M	$134.0M
YoY Change	-229.47%	-254.48%	-196.4%
% of Operating Profit	13.99%	-8.44%	6.02%
Other Income/Expense, Net	$262.0M	$106.0M	$122.0M
YoY Change	147.17%	-13.11%	-98.87%
Pretax Income	$1.879B	-$1.356B	$816.0M
YoY Change	-238.57%	-266.18%	-93.09%
Income Tax	$292.0M	-$769.0M	-$166.0M
% Of Pretax Income	15.54%		-20.34%
Net Earnings	-$1.046B	-$595.0M	$977.0M
YoY Change	75.8%	-160.9%	-86.65%
Net Earnings / Revenue	-10.03%	-5.88%	9.56%
Basic Earnings Per Share
Diluted Earnings Per Share	-$385.3K	-$215.8K	$347.2K
COMMON SHARES
Basic Shares Outstanding	2.724B shares	2.757B shares	2.794B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q4	2016 Q4	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.492B	$14.32B	$13.32B
YoY Change	-40.68%	7.44%	-15.35%
Cash & Equivalents	$6.092B	$6.515B	$8.524B
Short-Term Investments	$2.400B	$7.800B	$4.800B
Other Short-Term Assets	$4.299B	$4.389B	$5.140B
YoY Change	-2.05%	-14.61%	9.62%
Inventory	$5.096B	$4.866B	$4.700B
Prepaid Expenses
Receivables	$6.873B	$7.018B	$6.484B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$24.77B	$30.61B	$29.75B
YoY Change	-19.1%	2.9%	-8.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.44B	$12.03B	$12.51B
YoY Change	3.43%	-3.85%	-4.79%
Goodwill	$18.28B	$18.16B	$17.72B
YoY Change	0.67%	2.48%	36.41%
Intangibles	$14.18B	$17.31B	$22.60B
YoY Change	-18.04%	-23.44%	10.87%
Long-Term Investments	$767.0M	$715.0M	$702.0M
YoY Change	7.27%	1.85%	108.31%
Other Assets	$5.308B	$5.139B	$6.037B
YoY Change	3.29%	-14.87%	16.19%
Total Long-Term Assets	$63.11B	$64.76B	$71.93B
YoY Change	-2.56%	-9.96%	9.71%
TOTAL ASSETS
Total Short-Term Assets	$24.77B	$30.61B	$29.75B
Total Long-Term Assets	$63.11B	$64.76B	$71.93B
Total Assets	$87.87B	$95.38B	$101.7B
YoY Change	-7.87%	-6.2%	3.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.102B	$2.807B	$2.533B
YoY Change	10.51%	10.82%	-3.5%
Accrued Expenses	$10.26B	$10.17B	$11.18B
YoY Change	0.91%	-9.01%	7.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.000B	$300.0M	$2.300B
YoY Change	900.0%	-86.96%	130.0%
Total Short-Term Liabilities	$18.61B	$17.20B	$19.20B
YoY Change	8.2%	-10.4%	4.37%
LONG-TERM LIABILITIES
Long-Term Debt	$21.35B	$24.27B	$23.83B
YoY Change	-12.03%	1.87%	27.43%
Other Long-Term Liabilities	$11.12B	$8.514B	$7.345B
YoY Change	30.57%	15.92%	-5.99%
Total Long-Term Liabilities	$32.47B	$32.79B	$31.17B
YoY Change	-0.97%	5.18%	17.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.61B	$17.20B	$19.20B
Total Long-Term Liabilities	$32.47B	$32.79B	$31.17B
Total Liabilities	$51.08B	$49.99B	$50.38B
YoY Change	2.18%	-0.76%	12.17%
SHAREHOLDERS EQUITY
Retained Earnings	$41.35B	$44.13B	$45.35B
YoY Change	-6.31%	-2.68%	-1.46%
Common Stock	$41.69B	$41.73B	$42.01B
YoY Change	-0.09%	-0.67%	-0.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$43.79B	$40.55B	$38.53B
YoY Change	8.01%	5.22%	9.28%
Treasury Stock Shares	880.5M shares	828.4M shares	796.0M shares
Shareholders Equity	$34.34B	$40.09B	$44.68B
YoY Change
Total Liabilities & Shareholders Equity	$87.87B	$95.38B	$101.7B
YoY Change	-7.87%	-6.2%	3.58%

Cashflow Statement

Concept	2017 Q4	2016 Q4	2015 Q4
OPERATING ACTIVITIES
Net Income	-$1.046B	-$595.0M	$977.0M
YoY Change	75.8%	-160.9%	-86.65%
Depreciation, Depletion And Amortization	$1.128B	$1.155B	$1.560B
YoY Change	-2.34%	-25.96%	-0.83%
Cash From Operating Activities	$4.015B	$3.632B	$4.129B
YoY Change	10.55%	-12.04%	-454.73%
INVESTING ACTIVITIES
Capital Expenditures	-$715.0M	-$551.0M	-$493.0M
YoY Change	29.76%	11.76%	0.61%
Acquisitions
YoY Change
Other Investing Activities	$657.0M	-$2.012B	-$124.0M
YoY Change	-132.65%	1522.58%	-101.61%
Cash From Investing Activities	-$58.00M	-$2.563B	-$617.0M
YoY Change	-97.74%	315.4%	-108.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-5.785B	-1.977B	-2.289B
YoY Change	192.62%	-13.63%	-76.26%
NET CHANGE
Cash From Operating Activities	4.015B	3.632B	4.129B
Cash From Investing Activities	-58.00M	-2.563B	-617.0M
Cash From Financing Activities	-5.785B	-1.977B	-2.289B
Net Change In Cash	-1.828B	-908.0M	1.223B
YoY Change	101.32%	-174.24%	-133.94%
FREE CASH FLOW
Cash From Operating Activities	$4.015B	$3.632B	$4.129B
Capital Expenditures	-$715.0M	-$551.0M	-$493.0M
Free Cash Flow	$4.730B	$4.183B	$4.622B
YoY Change	13.08%	-9.5%	-785.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000310158
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2696190502	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	174700000000	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	Merck & Co., Inc.
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2017	dei	Trading Symbol TradingSymbol	MRK
CY2016Q4	invest	Derivative Notional Amount DerivativeNotionalAmount	25539000000	USD
CY2017Q4	invest	Derivative Notional Amount DerivativeNotionalAmount	25595000000	USD
CY2017Q4	mrk	Accounts Receivable Outstanding For More Than One Year AccountsReceivableOutstandingForMoreThanOneYear	130000000	USD
CY2016Q4	mrk	Accrual For Chargebacks AccrualForChargebacks	196000000	USD
CY2017Q4	mrk	Accrual For Chargebacks AccrualForChargebacks	198000000	USD
CY2016Q4	mrk	Accrual For Rebates AccrualForRebates	2700000000	USD
CY2017Q4	mrk	Accrual For Rebates AccrualForRebates	2400000000	USD
CY2015Q1	mrk	Agreement Term AgreementTerm	P2Y
CY2015	mrk	Charge For License Options Related To Collaboration ChargeForLicenseOptionsRelatedToCollaboration	0	USD
CY2016	mrk	Charge For License Options Related To Collaboration ChargeForLicenseOptionsRelatedToCollaboration	0	USD
CY2017	mrk	Charge For License Options Related To Collaboration ChargeForLicenseOptionsRelatedToCollaboration	500000000	USD
CY2016Q4	mrk	Company Pension Investments Which Are Categorized As Level Three Assets Percentage CompanyPensionInvestmentsWhichAreCategorizedAsLevelThreeAssetsPercentage	0.02
CY2017Q4	mrk	Company Pension Investments Which Are Categorized As Level Three Assets Percentage CompanyPensionInvestmentsWhichAreCategorizedAsLevelThreeAssetsPercentage	0.02
CY2015	mrk	Costs Expenses And Other CostsExpensesAndOther	34097000000	USD
CY2016	mrk	Costs Expenses And Other CostsExpensesAndOther	35148000000	USD
CY2017	mrk	Costs Expenses And Other CostsExpensesAndOther	33601000000	USD
CY2016Q4	mrk	Deferred Tax Assets Operating Loss Carryforwards And Other Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndOtherTaxCreditCarryforwards	437000000	USD
CY2017Q4	mrk	Deferred Tax Assets Operating Loss Carryforwards And Other Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndOtherTaxCreditCarryforwards	654000000	USD
CY2016Q4	mrk	Deferred Tax Assets Unrecognized Tax Benefits DeferredTaxAssetsUnrecognizedTaxBenefits	383000000	USD
CY2017Q4	mrk	Deferred Tax Assets Unrecognized Tax Benefits DeferredTaxAssetsUnrecognizedTaxBenefits	156000000	USD
CY2016Q4	mrk	Deferred Tax Liabilities Pensions And Other Postretirement Benefit Plans DeferredTaxLiabilitiesPensionsAndOtherPostretirementBenefitPlans	109000000	USD
CY2017Q4	mrk	Deferred Tax Liabilities Pensions And Other Postretirement Benefit Plans DeferredTaxLiabilitiesPensionsAndOtherPostretirementBenefitPlans	192000000	USD
CY2015	mrk	Effective Income Tax Rate Reconciliation Amortization Of Purchase Accounting Adjustments EffectiveIncomeTaxRateReconciliationAmortizationOfPurchaseAccountingAdjustments	0.148
CY2016	mrk	Effective Income Tax Rate Reconciliation Amortization Of Purchase Accounting Adjustments EffectiveIncomeTaxRateReconciliationAmortizationOfPurchaseAccountingAdjustments	0.134
CY2017	mrk	Effective Income Tax Rate Reconciliation Amortization Of Purchase Accounting Adjustments EffectiveIncomeTaxRateReconciliationAmortizationOfPurchaseAccountingAdjustments	0.109
CY2015	mrk	Effective Income Tax Rate Reconciliation Health Care Reform EffectiveIncomeTaxRateReconciliationHealthCareReform	0.012
CY2016	mrk	Effective Income Tax Rate Reconciliation Health Care Reform EffectiveIncomeTaxRateReconciliationHealthCareReform	0.014
CY2017	mrk	Effective Income Tax Rate Reconciliation Health Care Reform EffectiveIncomeTaxRateReconciliationHealthCareReform	0.011
CY2015	mrk	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Amount	0	USD
CY2016	mrk	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Amount	0	USD
CY2017	mrk	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Amount	2625000000	USD
CY2015	mrk	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent	0.000
CY2016	mrk	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent	0.000
CY2017	mrk	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent	0.403
CY2015	mrk	Effective Income Tax Rate Reconciliation Unremitted Foreign Earnings EffectiveIncomeTaxRateReconciliationUnremittedForeignEarnings	0.048
CY2016	mrk	Effective Income Tax Rate Reconciliation Unremitted Foreign Earnings EffectiveIncomeTaxRateReconciliationUnremittedForeignEarnings	-0.006
CY2017	mrk	Effective Income Tax Rate Reconciliation Unremitted Foreign Earnings EffectiveIncomeTaxRateReconciliationUnremittedForeignEarnings	0.000
CY2017	mrk	Estimate Of Cumulative Pre Tax Costs That Will Be Noncash EstimateOfCumulativePreTaxCostsThatWillBeNoncash	0.3333
CY2017	mrk	Estimate Of Cumulative Pre Tax Costs That Will Result In Cash Outlays EstimateOfCumulativePreTaxCostsThatWillResultInCashOutlays	0.6667
CY2015	mrk	In Process Research And Development Reclassified Upon Receipt Of Marketing Approval InProcessResearchAndDevelopmentReclassifiedUponReceiptOfMarketingApproval	280000000	USD
CY2016	mrk	In Process Research And Development Reclassified Upon Receipt Of Marketing Approval InProcessResearchAndDevelopmentReclassifiedUponReceiptOfMarketingApproval	8000000	USD
CY2017	mrk	In Process Research And Development Reclassified Upon Receipt Of Marketing Approval InProcessResearchAndDevelopmentReclassifiedUponReceiptOfMarketingApproval	14000000	USD
CY2015	mrk	Income Tax Reconciliation Amortization Of Purchase Accounting Adjustments IncomeTaxReconciliationAmortizationOfPurchaseAccountingAdjustments	797000000	USD
CY2016	mrk	Income Tax Reconciliation Amortization Of Purchase Accounting Adjustments IncomeTaxReconciliationAmortizationOfPurchaseAccountingAdjustments	623000000	USD
CY2017	mrk	Income Tax Reconciliation Amortization Of Purchase Accounting Adjustments IncomeTaxReconciliationAmortizationOfPurchaseAccountingAdjustments	713000000	USD
CY2015	mrk	Income Tax Reconciliation Foreign Income Unremitted Foreign Earnings IncomeTaxReconciliationForeignIncomeUnremittedForeignEarnings	260000000	USD
CY2016	mrk	Income Tax Reconciliation Foreign Income Unremitted Foreign Earnings IncomeTaxReconciliationForeignIncomeUnremittedForeignEarnings	-30000000	USD
CY2017	mrk	Income Tax Reconciliation Foreign Income Unremitted Foreign Earnings IncomeTaxReconciliationForeignIncomeUnremittedForeignEarnings	0	USD
CY2015	mrk	Income Tax Reconciliation Health Care Reform IncomeTaxReconciliationHealthCareReform	66000000	USD
CY2016	mrk	Income Tax Reconciliation Health Care Reform IncomeTaxReconciliationHealthCareReform	68000000	USD
CY2017	mrk	Income Tax Reconciliation Health Care Reform IncomeTaxReconciliationHealthCareReform	74000000	USD
CY2016Q4	mrk	Inventory Net And Inventory Noncurrent InventoryNetAndInventoryNoncurrent	5983000000	USD
CY2017Q4	mrk	Inventory Net And Inventory Noncurrent InventoryNetAndInventoryNoncurrent	6283000000	USD
CY2017	mrk	Maximum Debt To Capitalization Ratio Allowable MaximumDebtToCapitalizationRatioAllowable	0.60
CY2015	mrk	Other Nonoperating Income Expense Other OtherNonoperatingIncomeExpenseOther	-72000000	USD
CY2016	mrk	Other Nonoperating Income Expense Other OtherNonoperatingIncomeExpenseOther	-267000000	USD
CY2017	mrk	Other Nonoperating Income Expense Other OtherNonoperatingIncomeExpenseOther	304000000	USD
CY2017	mrk	Percentageofsettlementtobepaidtothirdparty Percentageofsettlementtobepaidtothirdparty	0.20
CY2016	mrk	Restructuring Reserve Noncash Activity RestructuringReserveNoncashActivity	413000000	USD
CY2017	mrk	Restructuring Reserve Noncash Activity RestructuringReserveNoncashActivity	-1000000	USD
CY2017	mrk	Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Deferred Tax Liabilities Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateDeferredTaxLiabilitiesProvisionalIncomeTaxExpenseBenefit	779000000	USD
CY2017Q4	mrk	Tax Cutsand Jobs Actof2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Liability Noncurrent TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalLiabilityNoncurrent	4500000000	USD
CY2015	mrk	Tax Cutsand Jobs Actof2017 Incomplete Accounting Transition Taxfor Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	0	USD
CY2016	mrk	Tax Cutsand Jobs Actof2017 Incomplete Accounting Transition Taxfor Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	0	USD
CY2017	mrk	Tax Cutsand Jobs Actof2017 Incomplete Accounting Transition Taxfor Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	5300000000	USD
CY2017	mrk	Tax Cutsand Jobs Actof2017 Incomplete Accounting Transition Taxfor Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	5347000000	USD
CY2017Q4	mrk	Tax Cutsand Jobs Actof2017 Incomplete Accounting Transition Taxfor Accumulated Foreign Earnings Provisional Liability TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalLiability	5100000000	USD
CY2017Q4	mrk	Tax Cutsand Jobs Actof2017 Incomplete Accounting Transition Taxfor Accumulated Foreign Earnings Provisional Liability Current TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalLiabilityCurrent	545000000	USD
CY2017	mrk	Term For Paying Off Environmental Liabilities TermForPayingOffEnvironmentalLiabilities	P15Y
CY2015	mrk	Translation Adjustments For Net Investment Hedge Pretax TranslationAdjustmentsForNetInvestmentHedgePretax	304000000	USD
CY2016	mrk	Translation Adjustments For Net Investment Hedge Pretax TranslationAdjustmentsForNetInvestmentHedgePretax	193000000	USD
CY2017	mrk	Translation Adjustments For Net Investment Hedge Pretax TranslationAdjustmentsForNetInvestmentHedgePretax	-520000000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2807000000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3102000000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7018000000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6873000000	USD
CY2016Q4	us-gaap	Accrual For Environmental Loss Contingencies AccrualForEnvironmentalLossContingencies	83000000	USD
CY2017Q4	us-gaap	Accrual For Environmental Loss Contingencies AccrualForEnvironmentalLossContingencies	82000000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2239000000	USD
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	708000000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15749000000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16602000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5226000000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4910000000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	39939000000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	39902000000	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	2100000000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	2100000000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	2200000000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	195000000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	210000000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4800000000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3800000000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3200000000	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9000000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13000000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5000000	shares
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges	162000000	USD
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3948000000	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	646000000	USD
CY2016Q4	us-gaap	Assets Assets	95377000000	USD
CY2017Q4	us-gaap	Assets Assets	87872000000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	30614000000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	24766000000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	20179000000	USD
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	15183000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	89000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	27000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	68000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	85000000	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	20158000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	15241000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	11100000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2400000000	USD
CY2016Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	11439000000	USD
CY2017Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	11726000000	USD
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	1.65
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	1.63
CY2015	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	4640000000	USD
CY2015	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	39584000000	USD
CY2016	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	733000000	USD
CY2017	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	3000000	USD
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-407000000	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	141000000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	590000000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	891000000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	935000000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	315000000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7441000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8524000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6092000000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1083000000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2009000000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-423000000	USD
CY2015	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.81
CY2016	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.85
CY2017	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.89
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3577103522	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3577103522	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1788000000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	1788000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4617000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2842000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2710000000	USD
CY2017	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.40
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1871000000	USD
CY2017Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2301000000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	14934000000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	13891000000	USD
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	12775000000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	732000000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1166000000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5585000000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	844000000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	916000000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1229000000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1706000000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2239000000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6724000000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	130000000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	157000000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-90000000	USD
CY2016Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	24800000000	USD
CY2017Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	24400000000	USD
CY2016Q4	us-gaap	Debt Current DebtCurrent	568000000	USD
CY2017Q4	us-gaap	Debt Current DebtCurrent	3057000000	USD
CY2016Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	25700000000	USD
CY2017Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	25600000000	USD
CY2017Q4	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	585000000	USD
CY2017	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2017Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	165000000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-552000000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1255000000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2958000000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-163000000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-225000000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	75000000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-764000000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1521000000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2621000000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7640000000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3820000000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5077000000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2219000000	USD
CY2016Q4	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	5854000000	USD
CY2017Q4	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	6075000000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-49000000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-41000000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	262000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	86000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	307000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3377000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3074000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	30000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	29000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3109000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2174000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	24000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	630000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1248000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1088000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	28000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	28000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	727000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	498000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	438000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	314000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	268000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	900000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4531000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1646000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	660000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	499000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3854000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2435000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	46000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	19000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	927000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	642000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	2044000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	33000000	USD
CY2016Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	18400000000	USD
CY2017Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	20500000000	USD
CY2017	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Decrease On Accumulated Postretirement Benefit Obligation1 DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1	104000000	USD
CY2017	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Decrease On Service And Interest Cost Components1 DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1	11000000	USD
CY2017	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation	125000000	USD
CY2017	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Increase On Service And Interest Cost Components DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents	13000000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	125000000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	126000000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	131000000	USD
CY2015	us-gaap	Depreciation Depreciation	1600000000	USD
CY2016	us-gaap	Depreciation Depreciation	1600000000	USD
CY2017	us-gaap	Depreciation Depreciation	1500000000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6375000000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5441000000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4637000000	USD
CY2016Q4	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	335000000	USD
CY2017Q4	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	33000000	USD
CY2016Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	131000000	USD
CY2017Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	94000000	USD
CY2016Q4	us-gaap	Derivative Assets DerivativeAssets	995000000	USD
CY2017Q4	us-gaap	Derivative Assets DerivativeAssets	130000000	USD
CY2016Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	529000000	USD
CY2017Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	3000000	USD
CY2016Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2017Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2017	us-gaap	Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred	-184000000	USD
CY2016Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	134000000	USD
CY2017Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	217000000	USD
CY2016Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	3000000	USD
CY2017Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	123000000	USD
CY2016Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	131000000	USD
CY2017Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	94000000	USD
CY2015	us-gaap	Derivative Net Hedge Ineffectiveness Gain Loss DerivativeNetHedgeIneffectivenessGainLoss	7000000	USD
CY2016	us-gaap	Derivative Net Hedge Ineffectiveness Gain Loss DerivativeNetHedgeIneffectivenessGainLoss	1000000	USD
CY2017	us-gaap	Derivative Net Hedge Ineffectiveness Gain Loss DerivativeNetHedgeIneffectivenessGainLoss	5000000	USD
CY2015	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	5115000000	USD
CY2016	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	5135000000	USD
CY2017	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	5177000000	USD
CY2016Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1316000000	USD
CY2017Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1320000000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.58
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.42
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.41
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1310000000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-131000000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	457000000	USD
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.174
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.154
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.629
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.007
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.001
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.097
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.397
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.353
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.265
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.059
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.000
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Restructuring Charges EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges	0.031
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Restructuring Charges EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges	0.031
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Restructuring Charges EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges	0.022
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.036
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.052
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.055
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.037
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.012
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.077
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.055
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	469000000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M25D
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	93000000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	92000000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	57000000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	109000000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	147000000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	73000000	USD
CY2017	us-gaap	Environmental Exit Costs Reasonably Possible Additional Loss EnvironmentalExitCostsReasonablyPossibleAdditionalLoss	63000000	USD
CY2015	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	50000000	USD
CY2016	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	16000000	USD
CY2017	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2000000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	715000000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	767000000	USD
CY2017Q4	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	810000000	USD
CY2016Q4	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.115
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	25000000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	100000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	32779000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	35948000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2800000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1100000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1100000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1200000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1500000000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1277000000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-174000000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	11000000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-876000000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	USD
CY2017	us-gaap	Gain Contingency Patents Allegedly Infringed Upon Number GainContingencyPatentsAllegedlyInfringedUponNumber	2	patent
CY2017Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-80000000	USD
CY2015	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2016	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-625000000	USD
CY2017	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-191000000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	17723000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	18162000000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	18284000000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	482000000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	177000000	USD
CY2016Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	187000000	USD
CY2017Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	225000000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	47000000	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	38000000	USD
CY2016	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	4000000	USD
CY2017	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-17000000	USD
CY2015	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	45000000	USD
CY2016	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	347000000	USD
CY2017	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	58000000	USD
CY2015	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	63000000	USD
CY2016	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	3600000000	USD
CY2017	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	483000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2247000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	518000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3483000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5401000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4659000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6521000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3154000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4141000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3038000000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	205000000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	86000000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	42000000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	942000000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	718000000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4103000000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	39000000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5000000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	632000000	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2144000000	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1646000000	USD
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1725000000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1890000000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1631000000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2282000000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	321000000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	0	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	0	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Restructuring Charges IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges	167000000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Restructuring Charges IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges	145000000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Restructuring Charges IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges	142000000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-196000000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-241000000	USD
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-361000000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	159000000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	173000000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	77000000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	-417000000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	0	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	-356000000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	1800000000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	1800000000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	4900000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-37000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	278000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	254000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	480000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	619000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-297000000	USD
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-266000000	USD
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	124000000	USD
CY2017	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3291000000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-8000000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2018000000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-922000000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-805000000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-206000000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	145000000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	5000000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-237000000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1091000000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-277000000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-809000000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-123000000	USD
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	50084000000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	50131000000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17305000000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14183000000	USD
CY2016	us-gaap	Interest Expense InterestExpense	693000000	USD
CY2017	us-gaap	Interest Expense InterestExpense	754000000	USD
CY2015	us-gaap	Interest Paid InterestPaid	653000000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1304000000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1334000000	USD
CY2015	us-gaap	Interest Expense InterestExpense	672000000	USD
CY2016	us-gaap	Interest Paid InterestPaid	686000000	USD
CY2017	us-gaap	Interest Paid InterestPaid	723000000	USD
CY2016Q4	us-gaap	Inventory Gross InventoryGross	5681000000	USD
CY2017Q4	us-gaap	Inventory Gross InventoryGross	6238000000	USD
CY2016Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	-302000000	USD
CY2017Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	-45000000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	4866000000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	5096000000	USD
CY2016Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1117000000	USD
CY2017Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1187000000	USD
CY2016Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	4222000000	USD
CY2017Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	4703000000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	289000000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	328000000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	385000000	USD
CY2016Q4	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	2300000000	USD
CY2017Q4	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	2200000000	USD
CY2016Q4	us-gaap	Land Land	412000000	USD
CY2017Q4	us-gaap	Land Land	365000000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	95377000000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	87872000000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17204000000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18614000000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	6000000000.0	USD
CY2016Q1	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	200000000	USD
CY2016Q4	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	2540000000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	300000000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3000000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3000000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	2200000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2300000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1900000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1300000000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24274000000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	21353000000	USD
CY2016Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	14053000000	USD
CY2017Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	14649000000	USD
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7826000000	USD
CY2017Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2406000000	USD
CY2016Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	11416000000	USD
CY2017Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	12125000000	USD
CY2017	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	291000000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	220000000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	233000000	USD
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	15000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9044000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10006000000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	16000000	USD
CY2015	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-75000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5387000000	USD
CY2017	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	18000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4758000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3210000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2679000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12538000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10376000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6447000000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	4442000000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	3920000000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	2394000000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17000000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	21000000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	24000000	USD
CY2015	us-gaap	Noncash Contribution Expense NoncashContributionExpense	78000000	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	124000000	USD
CY2017	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	7000000	USD
CY2017Q4	us-gaap	Number Of Interest Rate Derivatives Held NumberOfInterestRateDerivativesHeld	26	interest_rate_swap
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	255000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	68000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	90000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	126000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	175000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	138000000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	303000000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	292000000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	327000000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4389000000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4299000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-70000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-44000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-58000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-126000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-66000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-446000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-208000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-169000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	401000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	175000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1078000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	316000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-579000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	799000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-419000000	USD
CY2016Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	155000000	USD
CY2015	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-1540000000	USD
CY2016	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	0	USD
CY2017Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	201000000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10274000000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10427000000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8514000000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11117000000	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-874000000	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-313000000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-269000000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1527000000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-720000000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12000000	USD
CY2015	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-221000000	USD
CY2016	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-482000000	USD
CY2017	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-38000000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4186000000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3434000000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4014000000	USD
CY2016	us-gaap	Payments For Restructuring PaymentsForRestructuring	760000000	USD
CY2017	us-gaap	Payments For Restructuring PaymentsForRestructuring	722000000	USD
CY2015	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5117000000	USD
CY2016	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5124000000	USD
CY2017	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5167000000	USD
CY2015	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	7598000000	USD
CY2016	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
CY2017	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	146000000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	780000000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	396000000	USD
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	16681000000	USD
CY2016	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	15651000000	USD
CY2017	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	10739000000	USD
CY2015	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1283000000	USD
CY2016	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1614000000	USD
CY2017	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1888000000	USD
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	316000000	USD
CY2016	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2017	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2015	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	715000000	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7938000000	USD
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1079000000	USD
CY2017	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2015	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-61000000	USD
CY2016	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-118000000	USD
CY2017	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-195000000	USD
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	40122000000	USD
CY2017	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-26000000	USD
CY2015	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	20413000000	USD
CY2016	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	14353000000	USD
CY2017	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	15664000000	USD
CY2016	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	170000000	USD
CY2017	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	85000000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	485000000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	939000000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	499000000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	4459000000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	3941000000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	2418000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27775000000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29041000000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12507000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12026000000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12439000000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2906000000	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2386000000	USD
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1103000000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6704000000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10124000000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10208000000	USD
CY2017Q4	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	13500000000	USD
CY2017Q4	us-gaap	Restructuring And Related Cost Expected Cost Remaining1 RestructuringAndRelatedCostExpectedCostRemaining1	500000000	USD
CY2015	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	1110000000	USD
CY2015	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	1100000000	USD
CY2016	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	1069000000	USD
CY2016	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	1100000000	USD
CY2017	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	927000000	USD
CY2015	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	3770	position
CY2016	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	2625	position
CY2017	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	2450	position
CY2017Q4	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Inception To Date RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate	43350	position
CY2015	us-gaap	Restructuring Charges RestructuringCharges	619000000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	651000000	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	776000000	USD
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	645000000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	541000000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	747000000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	44133000000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41350000000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	39498000000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	39807000000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10313000000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9762000000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9830000000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	299000000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	300000000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	312000000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P3Y
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.041
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.038
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.036
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.199
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.196
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.178
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.017
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.014
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.020
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	118000000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	26778000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	42.54
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	332000000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	444000000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	236000000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1537000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	4232000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.46
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.89
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.04
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	397000000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	45091000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36274000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	44.47
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.77
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	43.38
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	51.78
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	59.73
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	54.63
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	63.88
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.3333
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M12D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M12D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	384000000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y7M21D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M21D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	30000000	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	28000000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	30000000	USD
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11512000	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	40088000000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	34336000000	USD
CY2016Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	80634000000	USD
CY2017Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	78130000000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48791000000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44767000000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40308000000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34569000000	USD
CY2015	us-gaap	Stockholders Equity Other StockholdersEquityOther	733000000	USD
CY2016	us-gaap	Stockholders Equity Other StockholdersEquityOther	1139000000	USD
CY2017	us-gaap	Stockholders Equity Other StockholdersEquityOther	729000000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	828372200	shares
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	880491914	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	40546000000	USD
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	43794000000	USD
CY2015	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4186000000	USD
CY2016	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3434000000	USD
CY2017	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4014000000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3534000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3448000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3494000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1723000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	59000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	90000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1038000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	184000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	92000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	1388000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	886000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	341000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	102000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	134000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	183000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	198000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	196000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	146000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	53000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	75000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	520000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	94000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	43000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	11000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1600000000	USD
CY2015	us-gaap	Unusual Or Infrequent Item Net Of Insurance Proceeds UnusualOrInfrequentItemNetOfInsuranceProceeds	680000000	USD
CY2016	us-gaap	Unusual Or Infrequent Item Net Of Insurance Proceeds UnusualOrInfrequentItemNetOfInsuranceProceeds	0	USD
CY2017	us-gaap	Unusual Or Infrequent Item Net Of Insurance Proceeds UnusualOrInfrequentItemNetOfInsuranceProceeds	0	USD
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	25000000	shares
CY2016	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	21000000	shares
CY2017	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	18000000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2841000000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2787000000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2748000000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2816000000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2766000000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2730000000	shares
CY2017	us-gaap	Advertising Cost Policy Expensed Advertising Cost AdvertisingCostPolicyExpensedAdvertisingCost	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Advertising and Promotion Costs —</font><font style="font-family:inherit;font-size:10pt;"> Advertising and promotion costs are expensed as incurred. </font></div></div>
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:20px;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of Operations</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Merck & Co., Inc. (Merck or the Company) is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The Company’s operations are principally managed on a products basis and include </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> operating segments, which are the Pharmaceutical, Animal Health, Healthcare Services and Alliances segments. The Pharmaceutical segment is the only reportable segment. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company sells these human health vaccines primarily to physicians, wholesalers, physician distributors and government entities. On December 31, 2016, Merck and Sanofi Pasteur S.A. (Sanofi) terminated their equally-owned joint venture, Sanofi Pasteur MSD (SPMSD), which developed and marketed vaccines in Europe. Beginning in 2017, Merck is recording vaccine sales and incurring costs as a result of operating its vaccines business in the European markets that were previously part of the SPMSD joint venture, which was accounted for as an equity method affiliate. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also has an Animal Health segment that discovers, develops, manufactures and markets animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. The Company’s Healthcare Services segment provides services and solutions that focus on engagement, health analytics and clinical services to improve the value of care delivered to patients.</font></div></div>
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications — </font><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform to the current year presentation.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates — </font><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (GAAP) and, accordingly, include certain amounts that are based on management’s best estimates and judgments. Estimates are used when accounting for amounts recorded in connection with acquisitions, including initial fair value determinations of assets and liabilities, primarily IPR&D, other intangible assets and contingent consideration, as well as subsequent fair value measurements. Additionally, estimates are used in determining such items as provisions for sales discounts and returns, depreciable and amortizable lives, recoverability of inventories, including those produced in preparation for product launches, amounts recorded for contingencies, environmental liabilities and other reserves, pension and other postretirement benefit plan assumptions, share-based compensation assumptions, restructuring costs, impairments of long-lived assets (including intangible assets and goodwill) and investments, and taxes on income. Because of the uncertainty inherent in such estimates, actual results may differ from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000310158-18-000005-index-headers.html	Edgar Link	pending
0000310158-18-000005-index.html	Edgar Link	pending
0000310158-18-000005.txt	Edgar Link	pending
0000310158-18-000005-xbrl.zip	Edgar Link	pending
electronicsignaturedavisa04.jpg	Edgar Link	pending
ex1012_2018nqsogranttermsu.htm	Edgar Link	pending
ex1017_2018restrictedstock.htm	Edgar Link	pending
ex1024planfordeferredpayme.htm	Edgar Link	pending
ex12computationofratiosofe.htm	Edgar Link	pending
ex21subsidiarylistasof1231.htm	Edgar Link	pending
ex23consentofindependentre.htm	Edgar Link	pending
ex241powerofattorneymrk123.htm	Edgar Link	pending
ex242certificationofboardr.htm	Edgar Link	pending
ex311rule13a-14a15dx14acer.htm	Edgar Link	pending
ex312rule13a-14a15dx14acer.htm	Edgar Link	pending
ex321section1350certificat.htm	Edgar Link	pending
ex322section1350certificat.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g438975g32h99a01a04.jpg	Edgar Link	pending
mrk-20171231.xml	Edgar Link	completed
mrk-20171231.xsd	Edgar Link	pending
mrk-20171231_cal.xml	Edgar Link	unprocessable
mrk-20171231_def.xml	Edgar Link	unprocessable
mrk-20171231_lab.xml	Edgar Link	unprocessable
mrk-20171231_pre.xml	Edgar Link	unprocessable
mrk1231201710k.htm	Edgar Link	pending
mrk1231201_chart-58501a04.jpg	Edgar Link	pending
pwcsignature2013a04.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MRK
Merck & Co., Inc. Stock $mrk

2017 Q4 Form 10-K Financial Statement

#000031015818000005 Filed on February 27, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRK Merck & Co., Inc. Stock $mrk

2017 Q4 Form 10-K Financial Statement

#000031015818000005 Filed on February 27, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRK
Merck & Co., Inc. Stock $mrk